The global gene therapy in CNS disorder market is poised for unprecedented growth, with market valuation anticipated to skyrocket from USD 8.2 billion in 2023 to USD 113.04 billion by 2033, registering a robust compound annual growth rate (CAGR) of 30% during the forecast period. This remarkable growth trajectory reflects increasing advancements and demand for …
Tag Archives: Gene Therapy in CNS Disorder Market
Global Gene Therapy Market for CNS Disorders Projected to Reach USD 113.04 Billion by 2033 at a 30% CAGR
The global gene therapy market for central nervous system (CNS) disorders is set for remarkable growth, with an expected valuation of US$ 8.2 billion in 2023 and projected to soar to approximately US$ 113.04 billion by 2033. This growth represents a staggering compound annual growth rate (CAGR) of 30% during the forecast period from 2023 …
Gene Therapy in CNS Disorder Market Forecast 2023 to 2033 | By Type, Indication, End-Users & Region
The global Gene Therapy in CNS Disorders Market size is expected to reach US$ 8.2 billion in 2023 and US$ 103.04 billion by 2033, with a compound annual growth rate (CAGR) of 30% between 2023 and 2033. The market for gene therapy in CNS diseases grew at a 19% CAGR from 2018 to 2022. The …